Elevian
PrivateLast Round
Series A
Sep 16, 2021
Est. Valuation
$100M
Total Funding Raised
$45.5M
Company Overview
Elevian is a biotechnology company that develops regenerative medicines aimed at halting and reversing the molecular damage associated with aging by targeting its root causes and enhancing the body's natural repair and regeneration processes to prevent and treat age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elevian Comparables
Compare Elevian with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Klotho Therapeutics, Inc. | 85% | |
| ADvantage Therapeutics Inc. | 78% | |
| Constant Therapeutics | 77% |
Elevian Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 16, 2021 | ||||
| VC Round | Nov 24, 2020 | ||||
| Seed | Sep 6, 2018 |
Elevian Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| For Good Ventures | VC Round |
| StartX | Seed |
| ArteFin GmbH | Seed |
| Kizoo Technology Capital | VC Round, Seed |
| Longevity Fund | VC Round, Seed |
| BOLD Capital Partners | VC Round, Series A, Seed |
| Thynk Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 24, 2020
$15M round led by Prime Movers Lab.
- Sep 6, 2018
$5.5M round led by Bold Capital
Elevian Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elevian's valuation, stock price, and market status.
Is Elevian a public or private company?
Elevian is a private company.
What is the current stock price of Elevian?
Elevian is a private company, so its shares have no public market price. Caplight tracks Elevian's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elevian worth (valuation)?
Elevian's valuation is estimated at $100.0M based on funding round data.
Can I buy Elevian stock?
Elevian shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elevian's last funding round?
Elevian's most recent funding round was Series A on September 16, 2021.
Who are the main investors in Elevian?
Key investors in Elevian include Prime Movers Lab, Bold Capital.
Will Elevian IPO soon?
No public IPO plans have been announced for Elevian.
How can I track Elevian secondary market activity?
Caplight tracks bids, offers, and trades in Elevian's shares on secondary markets.